QBFM
UTHR icon

QS Batterymarch Financial Management’s United Therapeutics UTHR Stock Holding History

QS Batterymarch Financial Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.26M Hold
17,550
– – 0.06% 390
2014
Q2 		$1.55M Buy
17,550
+6,350
+57% +$611K 0.04% 468
2014
Q1 		$1.05M Buy
11,200
+9,200
+460% +$941K 0.02% 650
2013
Q4 		$227K Hold
2,000
– – ﹤0.01% 854
2013
Q3 		$158K Buy
+2,000
New +$146K ﹤0.01% 913

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

QS Batterymarch Financial Management's UTHR Position: Q3 2014 in Review

QS Batterymarch Financial Management held its United Therapeutics (UTHR) position steady in Q3 2014 at 17,550 shares worth $2.26M. The position accounts for 0.06% of the portfolio, ranked #390.

QS Batterymarch Financial Management first reported a position in UTHR in Q3 2013 and has held it in 5 quarters since. 319 funds tracked by Wall St. Rank hold UTHR as of Q3 2014.

  • QS Batterymarch Financial Management held 17,550 shares of United Therapeutics worth $2.26M as of Q3 2014.
  • QS Batterymarch Financial Management left its United Therapeutics share count unchanged in Q3 2014.
  • United Therapeutics made up 0.06% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #390 holding.
  • QS Batterymarch Financial Management first reported a position in United Therapeutics in Q3 2013 and has held it in 5 quarters since.
  • 319 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.